Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0000318306-07-000012
Filing Date
2007-04-02
Accepted
2007-04-02 16:18:06
Documents
19
Period of Report
2007-04-02

Document Format Files

Seq Description Document Type Size
1 FORM 10KSB ex-10ksb2.htm 10KSB 1570672
2 AMEDNED ASSET SALE AGREEMENT ex10-16.htm EX-10.16 26347
3 NOTE AND WARRANT PURCHASE AGREEMENT 02-16-06 ex10-19.htm EX-10.19 332774
4 NOTE AND WARRANT PURCHASE AGREEMENT 10-24-06 ex10-24.htm EX-10.24 302815
5 SECURITY AGREEMENT ex10-25.htm EX-10.25 37373
6 FORM OF CONVERTIBLE NOTE ex10-26.htm EX-10.26 145678
7 FORM OF WARRANT ex10-27.htm EX-10.27 154173
8 INVESTOR RIGHTS AGREEMENT ex10-28.htm EX-10.28 151832
9 NOTE AND WARRANT PURCHASE AGREEMENT 12-6-06 ex10-29.htm EX-10.29 308072
10 SECURITY AGREEMENT ex10-30.htm EX-10.30 42111
11 FORM OF CONVERTIBLE NOTE ex10-31.htm EX-10.31 146946
12 FORM OF WARRANT ex10-32.htm EX-10.32 155951
13 INVESTOR RIGHTS AGREEMENT ex10-33.htm EX-10.33 152893
14 SUBSIDIARIES ex21.htm EX-21 3770
15 CONSENT WHITLEY PENN LLP ex23-1.htm EX-23.1 4996
16 CONSENT GRANT THORNTON LLP ex23-2.htm EX-23.2 5006
17 CEO CERTIFICATION ex31-1.htm EX-31.1 17730
18 CFO CERTIFICATION ex31-2.htm EX-31.2 7151
19 CEO-CFO CERTIFICATION ex32.htm EX-32 7154
  Complete submission text file 0000318306-07-000012.txt   3575066
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 001-15771 | Film No.: 07739230
SIC: 2834 Pharmaceutical Preparations